BACKGROUND: Genetic variants in KLK2 and KLK3 have been associated with increased serum concentrations of their encoded proteins, human kallikrein-related peptidase 2 (hK2) and prostate-specific antigen (PSA), and with prostate cancer in older men. Low PSA concentrations in seminal plasma (SP) have been associated with low sperm motility. To evaluate whether KLK2 and KLK3 genetic variants affect physiological prostatic secretion, we studied the association of SNPs with hK2 and PSA concentrations in SP and serum of young, healthy men.
to total PSA (tPSA). Both PSA and hK2 are noncatalytic in blood, with a relationship of free to bound forms that is opposite that in seminal fluid. hK2 in blood occurs predominantly in free unbound forms, whereas the majority of PSA is covalently bound in complexes with extracellular antiproteases such as ␣-1-antichymotrypsin (encoded by SERPINA3), and only 5%-35% circulates in free unbound forms (10 -12 ) . In healthy men, the PSA concentration in seminal plasma is 0.2-5 g/L (13 ) , and the retrograde release of PSA into the blood occurs with a frequency of Ͻ1 molecule per million secreted PSA molecules. hK2 is found in both seminal plasma and serum but at approximately 1% of the concentration of PSA (7, 14 ) . In men affected by prostate cancer, PSA and hK2 concentrations in blood become increased decades before cancer diagnosis (15, 16 ) , and the ratio of free to total PSA (%fPSA) decreases (17 ) . Only limited data have been reported on PSA and hK2 concentrations in men younger than 30 years. Concentrations of fPSA, but not cPSA, in serum correlate with PSA concentrations in seminal plasma in young men (18 ) . Low concentrations of PSA in seminal plasma have been shown to be associated with a reduced percentage of motile sperm (13 ) .
The risk of prostate cancer has been associated with single-nucleotide polymorphisms (SNPs) located in the genes coding for PSA (KLK3, kallikrein-related peptidase 3) (19 -24 ) and hK2 (KLK2, kallikreinrelated peptidase 2) (25) (26) (27) (28) (29) . Several SNPs in these genes have been associated with serum PSA and hK2 concentrations (22, 24 -26, 29 ) . The study cohorts have, however, been largely confined to older men, in whom the concentrations of these biomarkers may be affected by prostate cancer, benign prostatic hyperplasia, or prostatitis, all of which become more prevalent with age. Because measurement of PSA in serum is widely used for identifying subjects to be offered diagnostic procedures for detection of prostate cancer, it is important to know whether genetic factors may influence the non-cancer-related prostatic secretion of kallikreins. To address this question, we examined the relationship between SNPs in KLK2 and KLK3 and concentrations of hK2 and PSA in serum and seminal plasma by use of a population-based cohort of young men in whom prostate conditions are very rare.
Materials and Methods

PARTICIPANTS
A total of 305 men under compulsory medical examination for military service in Sweden were enrolled into a study of reproductive function in the year 2000 (30 ) . This group can be considered as representative for the Swedish general population of adolescent men, since at that time Ͼ95% of young men in Sweden underwent examination for military service. Their median age was 18.1 years (SD 0.4; range 18 -21 years), and median abstinence time was 85 h (SD 57; range 12-504 h). All men participated after giving written informed consent according to protocols approved by the ethics review board at Lund University. For the present study, not enough biospecimen material was available to measure all markers in all individuals; however, we expect the availability of biospecimen to be random with respect to the variables studied here.
SEMEN AND BLOOD SAMPLES
Semen samples obtained after masturbation were delivered between 0900 and 1100. A blood sample was subsequently drawn. All participating men were asked to abstain from sexual activities for at least 48 h and to note the actual abstinence time. Semen volume was determined by weighing the semen sample, assuming a density of 1 g/mL. For each semen sample, 450 L was mixed with 50 L of 0.1 mol/L benzamidine to inhibit liquefaction. Seminal plasma was obtained by centrifugation of the semen sample at 10 000g for 10 min. Blood and seminal plasma was kept at Ϫ70°C until analysis.
hK2 AND PSA ANALYSES
We analyzed seminal plasma samples for hK2 by use of a previously reported immunofluorometric assay (12 ) with minor modifications. The sample volume and extent of labeling of the tracer antibody were increased, and blocking of tPSA was enhanced by the use of 3 PSA-specific anti-PSA monoclonal antibodies (Mabs) (2E9, 5F7, and 5H6) that do not cross-react with hK2. The biotinylated Mab 6H10 was used to capture hK2. Finally, hK2 was detected by use of the Mab 7G1-Eu (31 ) . The CV for hK2 measurement in seminal plasma was 12% at a mean concentration of 0.008 g/L. We measured fPSA and tPSA in seminal plasma and serum by use of the commercially available assay Prostatus™ PSA Free/Total kit (Delfia® Reagents) (32 ) . The analysis for tPSA in seminal plasma measures the sum of fPSA (Ͼ95%), cPSA (1%-3%), and hK2 (Ͻ1%). The analysis of fPSA in seminal plasma measures the sum of active single-chain and inactive internally cleaved 2-chain fPSA. The combination of Mab H117 and H50 provides equimolar detection of fPSA and cPSA but also cross-reacts with hK2, whereas fPSA is measured by the combination of Mab H117 and 5A10 with no significant cross-reactivity to cPSA or hK2. CV for PSA measurements in seminal plasma was 12% at a mean concentration of 0.66 g/L. The detection limit in serum was 0.05 ng/mL (CV 5% at a mean concentration of 2.3 ng/mL) for tPSA and 0.04 ng/mL (CV 5.9% at a mean concentration of 0.25 ng/mL) for fPSA. Serum concen-trations of hK2, fPSA, and tPSA were analyzed in 303 men, seminal plasma tPSA in 293 men, and seminal plasma hK2 in 202 men due to missing semen and serum material. The characteristics of the study group are presented in Table 1 . We note that in previous work, intraindividual variability of these measures is Ͻ10%, and we presume the same holds here.
GENOTYPE ANALYSES
We prepared genomic DNA from peripheral leukocytes by use of a QIAamp DNA Maxi Kit (Qiagen). DNA concentrations were determined by PicoGreen™ DNA assay (Molecular Probes), and all samples were adjusted to the same DNA concentration. We determined genotypes by Sequenom MassArray MALDI-TOF analysis and made the assay design using MassArray Assay Design 2.0 software (Sequenom) as previously described (33 ) . We initially selected 9 SNPs for analysis on the basis of our prior observation of SNP/biomarker correlation in older men (29 ) , removing some redundant SNPs due to linkage disequilibrium (LD). One SNP, rs11670728 in KLK2, showed a significant deviation from Hardy-Weinberg equilibrium and was excluded from further analysis. The SNPs studied are described in Table 2 .
STATISTICAL ANALYSIS
We tested the observed genotype distribution for each SNP for consistency with Hardy-Weinberg equilibrium using the Fisher exact test. To estimate the strength of LD between all possible pairwise combinations of SNPs, we calculated DЈ using Haploview 4.0 (http://www.broad.mit.edu/mpg/haploview). The group characteristics of the seminal and serum concentrations of hK2, fPSA, and tPSA were summarized descriptively. We used the Kruskal-Wallis test to examine the associations between genotype at each SNP and kallikrein values (concentrations and absolute amounts of hK2 and PSA, in seminal plasma, and concentrations of hK2, tPSA, fPSA, and %fPSA, in serum). All statistical analyses were conducted by use of Stata 9.0 (Stata Corp.).
Results
Concentrations of hK2 and PSA in seminal plasma and serum were initially determined in 303 young Swedish men. The resulting data are summarized in Table 1 . We subsequently evaluated 9 SNPs from a 24-kbp region encompassing the KLK2 and KLK3 genes ( Table 2) for association with concentrations of hK2 and PSA in serum and seminal plasma. LD in the region was moderate, apart from one 1-kbp haplotype block in KLK2 extending from rs198977 through rs80050017 (Fig. 1 ).
SNPs ASSOCIATED WITH hK2 CONCENTRATIONS
SNP associations with hK2 concentrations in seminal plasma are presented in Table 3 and Supplementary  Fig. 1 (which accompanies the online version of this article at http://www.clinchem.org/content/vol60/ issue3); the associations for serum are presented in Table 4 and online Supplementary Fig. 2 . The genotypes of all 4 KLK2 SNPs (rs198972, rs198977, rs198978, and rs80050017) were strongly associated with hK2 amount and concentration in seminal plasma and with hK2 concentration in serum (all P values Ͻ0.001). As very few rare homozygotes were observed for rs80050017, we also performed a 2-group comparison, removing the rare homozygotes, in which similar results were observed (see online Supplementary Table  1 ). In general, individuals homozygous for the major alleles showed higher hK2 values than individuals with the other genotypes. The effects were in all cases such that the heterozygotes had intermediate values compared with the homozygotes, and the effects were more pronounced in seminal plasma compared with serum. The effects were generally quite strong; in most cases, there was a Ͼ3-fold difference between the homozygotes. The rs198977 SNP showed the strongest effect, with 4-to 7-fold differences between the homozygotes. In addition, rs61752561 in KLK3 showed an association with hK2 amount and concentration in seminal plasma, but has a low minor allele frequency (MAF) of only 0.03. Notably, for all 4 SNPs associated with hK2 concentrations, ad hoc 2-group comparisons were consistently significant, with the exception of rs80050017, for which only the comparisons between common homozygotes and heterozygotes were significant (see online Supplementary Table 2 ).
SNPs ASSOCIATED WITH PSA CONCENTRATIONS
SNP associations with PSA concentrations in seminal plasma and serum are presented in Tables 3 and 4 , respectively. Graphical representations of selected significant results can be found in online Supplemental Tables 3 and 4. The genotypes of all 3 KLK3 SNPs (rs2271094, rs61752561, and rs1058205) were associated with PSA amount or concentration in seminal plasma (Table 3) . For rs1058205, the rare homozygote count was low; similar results are observed when the common homozygote group is compared to the heterozygote group (see online Supplementary Table 1) . However, the effects were less strong than observed for the KLK2 SNPs and hK2, as there were 0.8-to 1.3-fold differences between the homozygotes. Apart from the rs61752561 SNP with a low MAF, rs1058205 was the only KLK3 SNP showing significance for PSA in serum (Table 4) . Similarly, SNP rs1058205 showed a statistically significant association with higher seminal PSA amounts for the TT genotype (median tPSA amount 2.1 vs 1.6 mg for TT vs CC). Subjects with the TT genotype also tended to have higher median seminal plasma concentrations of PSA, although the difference did not reach significance (P ϭ 0.1). The same genotype was associated with significantly higher serum concentrations of tPSA (median 0.53 vs 0.44 ng/mL for TT vs CC genotype) and lower %fPSA (40% vs 49% for TT vs CC genotype). Although only the comparison between the TT and TC genotype of rs1058205 showed a significant difference in serum total PSA concentrations (see online Supplemental Table 2 ), a continuing trend for the C allele being associated with decreased total PSA concentrations in serum can be observed (see online Supplemental Fig. 2A ). In addition, the KLK2 SNPs (rs198972, rs198977, and rs198978) showed highly significant associations with %fPSA in serum. In all 3 cases, individuals homozygous for the minor alleles showed higher values of %fPSA (rs198972, 47% vs 38% for TT vs CC; rs198977, 44% vs 40% for TT vs CC; rs198978, 46% vs 37% for TT vs GG; all P Յ 0.007).
SIGNIFICANCE OF THE ASSOCIATIONS
The P values presented in Tables 3 and 4 are unadjusted for the multiple testing performed. A commonly used compensation for multiple testing is the Bonferroni correction, which simply divides the significance level by the number of tests. In the present study, a total of 64 
CORRELATION BETWEEN THE SNPs
Although LD appears to be moderate in this region (Fig. 1) , correlation between SNPs could still mean that some of the SNPs are tagging the same functional variant and thus are redundant. To examine this further, we calculated the pairwise correlation coefficient (r 2 ) between all pairs of SNPs on the basis of the phased haplotypes and examined pairs of SNPs for which r 2 Ͼ 0.2. The most correlated pair of SNPs is rs3760728 and rs2271094 (r 2 ϭ 0.60); these 2 SNPs are also both significantly associated with the concentration of PSA in seminal fluid. Additionally, numerous pairwise correlations between rs198972, rs198977, rs198978, and rs80050017 are observed; these SNPs are consistently associated with concentrations of hK2.
Given the strong association between several correlated SNPs and hK2 concentrations, we next asked which of the 4-marker haplotypes formed by rs198972, rs198977, rs198978, and rs80050017 are associated with hk2 concentrations. Of the 5 haplotypes with a frequency Ͼ5%, 4 are strongly associated with hK2 concentrations in blood and semen (Table 5 ). Of these, 2 are also associated with the ratio between free and total PSA (Table 5) . Notably, the 3 common haplotypes with a T allele at rs198977 are strongly associated with decreased hK2 concentrations, consistent with what was observed for single-marker tests.
Discussion
In the current study, we examined 9 previously reported SNPs in a 24-kbp KLK2-KLK3 region (28 ) for associations with hK2 and PSA concentrations in serum and seminal plasma in young men without prostate disease. For hK2, all 4 KLK2 SNPs showed association with hK2 concentrations both in seminal plasma and serum. Three of these SNPs (rs198977, rs198978, and rs80050017) formed a haplotype block, whereas the remaining SNP (rs198972) was in moderate LD with these SNPs. The strongest effect on hK2 concentration was observed for rs198977. Consistent with this observation, common haplotypes containing the T allele of rs198977 are associated with decreased concentrations of hK2. Whether the rs198977 SNP is causal or other SNPs in LD with this SNP are causing the observed lower concentrations of hK2 is unknown at present.
The SNP rs198977 has previously been associated with hK2 concentrations among older men (approximately 65-70 years old) with no prostate cancer diagnosis (25, 26, 29 ) ; as in this study, the T allele was consistently associated with lower concentrations. In all 3 prior studies, the T allele was also associated with slightly increased risk of prostate cancer. In contrast, a smaller study of Chinese men (27 ) reported increased risk of prostate cancer for men carrying the C allele. This discrepancy may possibly be explained by the different populations studied, but the differences nevertheless raise questions. The C-to-T substitution in rs198977 corresponds to an Arg226Trp change in hK2. An in vitro study suggested that the Trp 226 -hK2 variant lacked protease activity, although the experimental system did not allow a definitive assessment (34 ) . The observation that the T allele of rs198977 is associated with lower hK2 concentrations in multiple populations and among both young and old men suggests that it results from a basic aspect of hK2 biology resulting in lower hK2 expression. Another possibility is that the Trp 226 form of hK2 (encoded by the T allele) is more rapidly degraded or poorly detected by both of the different monoclonal antibodies, each capturing and detecting hK2 through uniquely distinct epitopes in our study and those by Nam and colleagues (25, 26 ) .
Several KLK3 SNPs showed associations with concentrations of PSA. The rs2271094 SNP was significantly associated with PSA amount and concentration in seminal plasma. For rs61752561, the GG genotype showed an association with lower PSA concentration in seminal plasma but with higher tPSA concentration in serum. Because this SNP has a MAF of only 0.03, these associations are likely due to chance. For a third KLK3 SNP, rs1058205, the TT genotype showed a statistically significant association with higher PSA amount in seminal plasma and higher tPSA concentration and lower %fPSA in serum. This decrease in %fPSA is a consequence of the increase in serum concentrations, which is due to the difference in mechanisms and rates of elimination of fPSA and complex-bound PSA. Our results with this SNP fit with a prior report in which the T variant was associated with higher serum tPSA in older men (22 ) . This variant was also associated with higher cancer risk in 1 study (24 ) , although subsequent studies failed to confirm this association (22, 29 ) . Moreover, we and others (22 ) have argued that KLK3 variants associated with higher tPSA concentrations may exhibit spurious associations with prostate cancer risk if PSA testing was involved in detection of the cancers.
Three KLK2 SNPs, rs198972, rs198977, and rs198978, were significantly associated with %fPSA in serum. In each case, the allele associated with higher %fPSA was also associated with lower hK2. How variants in KLK2 might affect the %fPSA is not entirely clear; however, we propose 2 possible explanations. The first is a protein-protein interaction between hK2 and PSA, in which a variant hK2 might selectively stabilize fPSA, thereby increasing %fPSA. Second, if hK2 is responsible for PSA processing in vivo, then variants that reduce hK2 concentration or protease activity (as suggested for Trp 226 -hK2) could result in decreased mature PSA and increased pro-PSA. Because pro-PSA is unable to form complexes with the serum antiproteases and therefore remains free in serum, the result would be an increase in the %fPSA. Interestingly, rs198977 was also associated with both hK2 and %fPSA in our prior study of older men (29 ) .
Other KLK3 SNPs have also been associated with PSA concentrations in blood. Several SNPs in the KLK3 promoter were reported to be associated with serum PSA concentrations (19, 20 ) , and 1 was associated with prostate cancer risk (35 ) , but later studies failed to confirm these associations (21, 36 -39 ) . In an earlier study of the same cohort, we found that a KLK3 promoter SNP, rs266882, in combination with androgen receptor gene CAG repeat length, was significantly associated with serum concentrations of tPSA (38 ) . In the same cohort, we have also recently shown that a MSMB-promoter SNP (rs10993994) at the genetic locus encoding ␤-microseminoprotein (␤-MSP) is significantly associated with blood and semen concentrations of PSA and semen concentrations of hK2 (40 ) . In the 3Ј flanking region of KLK3, rs2735839 was found to be associated with PSA concentration in 2 studies (22, 23 ) . In contrast, our previous study found an association for this SNP with %fPSA but not PSA concentration (29 ) .
The associations we and others have detected may have implications for PSA and hK2 testing in prostate cancer screening. For men carrying genetic variants associated with altered concentrations of PSA or hK2, prostate cancer risk models developed on the general population may be less accurate. Conversely, the combination of biomarker concentrations and genotype may offer a means of increasing the accuracy of prostate cancer prediction. These considerations are particularly applicable to the KLK2 SNP rs198977, for which the TT genotype is associated with dramatically lower hK2 concentrations, but with higher cancer risk. Indeed, a model incorporating rs198977 genotype and the interaction between genotype and hK2 concentration was suggested to have higher accuracy for predicting prostate cancer than a model with biomarker data alone (29 ) .
In conclusion, we documented the association of SNPs in KLK3 and KLK2 with concentrations of PSA and hK2 in young men. These results demonstrate that associations exist several decades before any substantial incidence of prostate cancer or other prostate conditions were found to influence kallikrein concentrations in the blood (16 ) . Moreover, most of the variants associated with altered tPSA or hK2 concentrations in serum were associated with corresponding albeit more pronounced alterations in seminal plasma. Therefore, the causative genetic variants most likely exert their effects through global changes in expression or protein stability, rather than being related to a prostate disease process. The information from analyses of variants in the KLK2 and KLK3 could also be used to refine models of PSA cutoff values in prostate cancer testing. In addition, because low concentrations of PSA are correlated with lower percentage of motile sperm in both fertile and infertile men, a better knowledge of the factors regulating the concentrations of hK2 and PSA is of importance to understanding the mechanisms behind male infertility.
